Abstract
This review summarises the functions of the enzyme tissue transglutaminase (TG2) in the extracellular matrix (ECM) both as a matrix stabiliser through its protein cross-linking activity and as an important cell adhesion protein involved in cell survival. The contribution of extracellular TG2 to the pathology of important diseases such as cancer and fibrosis are discussed with a view to the potential importance of TG2 as a therapeutic target. The medical applications of TG2 are further expanded by detailing the use of transglutaminase cross-linking in the development of novel biocompatible biomaterials for use in soft and hard tissue repair.



Similar content being viewed by others
References
Akimov SS, Belkin AM (2001a) Cell-surface transglutaminase promotes fibronectin assembly via interaction with the gelatin-binding domain of fibronectin: a role in TGF beta-dependent matrix deposition. J Cell Sci 114(16):2989–3000
Akimov SS, Belkin AM (2001b) Cell surface tissue transglutaminase is involved in adhesion and migration of monocytic cells on fibronectin. Blood 98(5):1567–1576
Akimov SS, Krylov D, Fleischman LF, Belkin AM (2000) Tissue transglutaminase is an integrin-binding adhesion co-receptor for fibronectin. J Cell Biol 148(4):825–838
Al-Jallad HF, Nakano Y, Chen JL, McMillan E, Lefebvre C, Kaartinen MT (2006) Transglutaminase activity regulates osteoblast differentiation and matrix mineralization in MC3T3–E1 osteoblast cultures. Matrix Biol 25(3):135–148
Balklava Z, Verderio E, Collighan R, Gross S, Adams J, Griffin M (2002) Analysis of tissue transglutaminase function in the migration of Swiss 3T3 fibroblasts: the active-state conformation of the enzyme does not affect cell motility but is important for its secretion. J Biol Chem 277(19):16567–16575
Barnes RN, Bungay PJ, Elliott BM, Walton PL, Griffin M (1985) Alterations in the distribution and activity of transglutaminase during tumor-growth and metastasis. Carcinogenesis 6(3):459–463
Belkin AM, Akimov SS, Zaritskaya LS, Ratnikov BI, Deryugina EI, Strongin AY (2001) Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion. J.Biol Chem 276(21):18415–18422
Bertoni F, Barbani N, Giusti P, Ciardelli G (2006) Transglutaminase reactivity with gelatine: perspective applications in tissue engineering. Biotechnol Lett 28(10):697–702
Birckbichler PJ, Patterson MK Jr (1978) Cellular transglutaminase, growth, and transformation. Ann N Y Acad Sci 312:354–365
Bowness JM, Folk JE, Timpl R (1987) Identification of a substrate site for liver transglutaminase on the aminopropeptide of type-III collagen. J Biol Chem 262(3):1022–1024
Bowness JM, Tarr AH, Wong T (1988) Increased transglutaminase activity during skin wound-healing in rats. Biochim Biophys Acta 967(2):234–240
Broderick EP, O’Halloran DM, Rochev YA, Griffin M, Collighan RJ, Pandit AS (2005) Enzymatic stabilization of gelatin-based scaffolds. J Biomed Mater Res B Appl Biomater 72B(1):37–42
Chau DYS, Collighan RJ, Griffin M (2007) Collagen: structure and modification for biomedical applications. In: Pannone P J (ed) Trends in biomaterials research. Nova Publishers, pp 143–190
Chau DYS, Collighan RJ, Verderio EAM, Addy VL, Griffin M (2005) The cellular response to transglutaminase-cross-linked collagen. Biomaterials 26(33):6518–6529
Chiono V, Ciardelli G, Vozzi G, Cortez J, Barbani N, Gentile P, Giusti P (2008) Enzymatically-modified melt-extruded guides for peripheral nerve repair. Eng Life Sci 8(3):226–237
Collier JH, Messersmith PB (2003) Enzymatic modification of self-assembled peptide structures with tissue transglutaminase. Bioconjugate Chem 14(4):748–755
Collighan R, Cortez J, Griffin M (2002) The biotechnological applications of transglutaminases. Minerva Biotechnol 14(2):143–148
Collighan RJ, Li X, Parry J, Griffin M, Clara S (2004) Transglutaminases as tanning agents for the leather industry. J Am Leather Chem Ass 99(7):293–302
Condello S, Caccamo D, Curro M, Ferlazzo N, Parisi G, Ientile R (2008) Transglutaminase 2 and NF-kappa B interplay during NGF-induced differentiation of neuroblastoma cells. Brain Res 1207:1–8
Damodaran G, Collighan R, Griffin M, Pandit A (2008) Tethering a laminin peptide to a crosslinked collagen scaffold for biofunctionality. J Biomed Mater A 13:13
Dardik R, Krapp T, Rosenthal E, Loscalzo J, Inbal A (2007) Effect of FXIII on monocyte and fibroblast function. Cell Physiol Biochem 19(1–4):113–120
Dardik R, Loscalzo J, Inbal A (2006) Factor XIII (FXIII) and angiogenesis. J Thromb Haemost 4(1):19–25
Dolynchuk KN, Ziesmann M, Serletti JM (1996) Topical putrescine (Fibrostat) in treatment of hypertrophic scars: phase II study. Plast Reconstr Surg 97(1):117–123
Engler AJ, Sen S, Sweeney HL, Discher DE (2006) Matrix elasticity directs stem cell lineage specification. Cell 126(4):677–689
Facchiano F, Facchiano A, Facchiano AM (2006) The role of transglutaminase-2 and its substrates in human diseases. Front Biosci 11:1758–1773
Fesus L, Szondy Z (2005) Transglutaminase 2 in the balance of cell death and survival. Febs Lett 579(15):3297–3302
Folk JE, Finlayson JS (1977) The epsilon-(gamma-glutamyl)lysine crosslink and the catalytic role of transglutaminases. Adv Protein Chem 31:1–133
Freund KF, Doshi KP, Gaul SL, Claremon DA, Remy DC, Baldwin JJ, Pitzenberger SM, Stern AM (1994) Transglutaminase inhibition by 2-(2-Oxopropyl)thio imidazolium derivative–mechanism of factor xiiia inactivation. Biochemistry 33(33):10109–10119
Friess W (1998) Collagen––biomaterial for drug delivery. Eur J Pharm Biopharm 45(2):113–136
Fuchsbauer HL, Gerber U, Engelmann J, Seeger T, Sinks C, Hecht T (1996) Influence of gelatin matrices cross-linked with transglutaminase on the properties of an enclosed bioactive material using beta-galactosidase as model system. Biomaterials 17(15):1481–1488
Garcia Y, Collighan R, Griffin M, Pandit A (2007) Assessment of cell viability in a three-dimensional enzymatically cross-linked collagen scaffold. J Mater Sci Mater Med 18(10):1991–2001
Garcia Y, Wilkins B, Collighan RJ, Griffin M, Pandit A (2008) Towards development of a dermal rudiment for enhanced wound healing response. Biomaterials 29(7):857–868
Gaudry CA, Verderio E, Aeschlimann D, Cox A, Smith C, Griffin M (1999a) Cell surface localization of tissue transglutaminase is dependent on a fibronectin-binding site in its N-terminal beta-sandwich domain. J Biol Chem 274(43):30707–30714
Gaudry CA, Verderio E, Jones RA, Smith C, Griffin M (1999b) Tissue transglutaminase is an important player at the surface of human endothelial cells: evidence for its externalization and its colocalization with the beta(1) integrin. Exp Cell Res 252(1):104–113
Gentile V, Cooper AJ (2004) Transglutaminases––possible drug targets in human diseases. Curr Drug Targets CNS Neurol Disord 3(2):99–104
Goodman M, Cai WB, Kinberger GA (2003) The new science of protein mimetics. Macromol Sym 201:223–236
Grenard P, Bresson-Hadni S, El Alaoui S, Chevallier M, Vuitton DA, Ricard-Blum S (2001) Transglutaminase-mediated cross-linking is involved in the stabilization of extracellular matrix in human liver fibrosis. J Hepatol 35(3):367–375
Griffin M, Casadio R, Bergamini CM (2002) Transglutaminases: nature’s biological glues. Biochem J 368:377–396
Griffin M, Mongeot A, Collighan R, Saint RE, Jones RA, Coutts IG, Rathbone DL (2008) Synthesis of potent water-soluble tissue transglutaminase inhibitors. Bioorg Med Chem Lett (in press)
Griffin M, Smith LL, Wynne J (1979) Changes in transglutaminase activity in an experimental model of pulmonary fibrosis induced by paraquat. Br J Exp Pathol 60(6):653–661
Griffin M, Wilson J (1984) Detection of epsilon(gamma-glutamyl) lysine. Mol Cell Biochem 58(1–2):37–49
Grigoriev MY, Suspitsin EN, Togo AV, Pozharisski KM, Ivanova OA, Nardacci R, Falasca L, Piacentini M, Imyanitov EN, Hanson KP (2001) Tissue transglutaminase expression in breast carcinomas. J Exp Clin Cancer Res 20(2):265–268
Gross SR, Balklava Z, Griffin M (2003) Importance of tissue transglutaminase in repair of extracellular matrices and cell death of dermal fibroblasts after exposure to a solarium ultraviolet a source. J Invest Dermatol 121(2):412–423
Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57–70
Hang J, Zemskov EA, Lorand L, Belkin AM (2005) Identification of a novel recognition sequence for fibronectin within the NH2-terminal beta-sandwich domain of tissue transglutaminase. J Biol Chem 280(25):23675–23683
Haroon ZA, Wannenburg T, Gupta M, Greenberg CS, Wallin R, Sane DC (2001) Localization of tissue transglutaminase in human carotid and coronary artery atherosclerosis: implications for plaque stability and progression. Lab Invest 81(1):83–93
Hasegawa G, Suwa M, Ichikawa Y, Ohtsuka T, Kumagai S, Kikuchi M, Sato Y, Saito Y (2003) A novel function of tissue-type transglutaminase: protein disulphide isomerase. Biochem J 373(Pt 3):793–803
Heath DJ, Christian P, Griffin M (2002) Involvement of tissue trans glutaminase in the stabilisation of biomaterial/tissue interfaces important in medical devices. Biomaterials 23(6):1519–1526
Herman JF, Mangala LS, Mehta K (2006) Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells. Oncogene 25(21):3049–3058
Holmes TC (2002) Novel peptide-based biomaterial scaffolds for tissue engineering. Trends Biotechnol 20(1):16–21
Holmes TC, de Lacalle S, Su X, Liu G, Rich A, Zhang S (2000) Extensive neurite outgrowth and active synapse formation on self-assembling peptide scaffolds. Proc Natl Acad Sci USA 97(12):6728–6733
Hu BH, Messersmith PB (2003) Rational design of transglutaminase substrate peptides for rapid enzymatic formation of hydrogels. J Am Chem Soc 125(47):14298–14299
Hu BH, Messersmith PB (2005) Enzymatically cross-linked hydrogels and their adhesive strength to biosurfaces. Orthod Craniofac Res 8(3):145–149
Ichinose A, Bottenus RE, Davie EW (1990) Structure of transglutaminases. J Biol Chem 265(23):13411–13414
Isobe T, Takahashi H, Ueki S, Takagi J, Saito Y (1999) Activity-independent cell adhesion to tissue-type transglutaminase is mediated by alpha 4 beta 1 integrin. Eur J Cell Biol 78(12):876–883
Ito A, Mase A, Takizawa Y, Shinkai M, Honda H, Hata K, Ueda M, Kobayashi T (2003) Transglutaminase-mediated gelatin matrices incorporating cell adhesion factors as a biomaterial for tissue engineering. J Biosci Bioeng 95(2):196–199
Jelenska M, Fesus L, Kopec M (1980) The comparative ability of plasma and tissue transglutaminases to use collagen as a substrate. Biochim Biophys Acta 616(2):167–178
Johnson KA, Terkeltaub RA (2005) External GTP-bound transglutaminase 2 is a molecular switch for chondrocyte hypertrophic differentiation and calcification. J Biol Chem 280(15):15004–150012
Johnson TS, Fisher M, Haylor JL, Hau Z, Skill NJ, Jones R, Saint R, Coutts I, Vickers ME, El Nahas AM, Griffini M (2007) Transglutaminase inhibition reduces fibrosis and preserves function in experimental chronic kidney disease 18(12):3078–3088
Johnson TS, Griffin M, Thomas GL, Skill J, Cox A, Yang B, Nicholas B, Birckbichler PJ, Muchaneta-Kubara C, ElNahas AM (1997) The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis. J Clin Invest 99(12):2950–2960
Johnson TS, Skill NJ, El Nahas AM, Oldroyd SD, Thomas GL, Douthwaite JA, Haylor JL, Griffin M (1999) Transglutaminase transcription and antigen translocation in experimental renal scarring. J Am Soc Nephrol 10(10):2146–2157
Jones MER, Messersmith PB (2007) Facile coupling of synthetic peptides and peptide-polymer conjugates to cartilage via transglutaminase enzyme. Biomaterials 28(35):5215–5224
Jones RA, Kotsakis P, Johnson TS, Chau DY, Ali S, Melino G, Griffin M (2006) Matrix changes induced by transglutaminase 2 lead to inhibition of angiogenesis and tumor growth. Cell Death Differ 13(9):1442–1453
Jurgensen K, Aeschlimann D, Cavin V, Genge M, Hunziker EB (1997) A new biological glue for cartilage-cartilage interfaces: tissue transglutaminase. J Bone Joint Surg-Am Vol 79A(2):185–193
Kaetsu H, Hashiguchi T, Foster D, Ichinose A (1996) Expression and release of the a and b subunits for human coagulation factor XIII in baby hamster kidney (BHK) cells. J Biochem (Tokyo) 119(5):961–969
Kawai Y, Wada F, Sugimura Y, Maki M, Hitomi K (2008) Transglutaminase 2 activity promotes membrane resealing after mechanical damage in the lung cancer cell line A549. Cell Biol Int 32(8):928–934
Khew ST, Yang QJ, Tong YW (2008) Enzymatically crosslinked collagen-mimetic dendrimers that promote integrin-targeted cell adhesion. Biomaterials 29(20):3034–3045
Kinberger GA, Cai W, Goodman M (2002) Collagen mimetic dendrimers. J Am Chem Soc 124(51):15162–15163
Kinberger GA, Taulane JP, Goodman M (2006) The design, synthesis, and characterization of a PAMAM-based triple helical collagen mimetic dendrimer. Tetrahedron 62(22):5280–5286
Kisiday J, Jin M, Kurz B, Hung H, Semino C, Zhang S, Grodzinsky AJ (2002) Self-assembling peptide hydrogel fosters chondrocyte extracellular matrix production and cell division: implications for cartilage tissue repair. Proc Natl Acad Sci USA 99(15):9996–10001
Kleman JP, Aeschlimann D, Paulsson M, van der Rest M (1995) Transglutaminase-catalyzed cross-linking of fibrils of collagen V/XI in A204 rhabdomyosarcoma cells. Biochemistry 34(42):13768–13775
Knight CRL, Rees RC, Griffin M (1991) Apoptosis––a potential role for cytosolic transglutaminase and its importance in tumor progression. Biochim Biophys Acta 1096(4):312–318
Kotsakis P, Griffin M (2007) Tissue transglutaminase in tumour progression: friend or foe? Amino Acids 33(2):373–384
Lee KN, Arnold SA, Birckbichler PJ, Patterson MK, Fraij BM, Takeuchi Y, Carter HA (1993) Site-directed mutagenesis of human tissue transglutaminase: Cys-277 is essential for transglutaminase activity but not for GTPase activity. Biochim Biophys Acta 1202(1):1–6
Linge C, Richardson J, Vigor C, Clayton E, Hardas B, Rolfe KJ (2005) Hypertrophic scar cells fail to undergo a form of apoptosis specific to contractile collagen––the role of tissue transglutaminase. J Invest Dermatol 125(1):72–82
Liu SP, Cerione RA, Clardy J (2002) Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity. Proc Natl Acad Sci USA 99(5):2743–2747
Mangala LS, Arun B, Sahin AA, Mehta K (2005) Tissue transglutaminase-induced alterations in extracellular matrix inhibit tumor invasion. Mol Cancer 4:33
Mangala LS, Fok JY, Zorrilla-Calancha IR, Verma A, Mehta K (2007) Tissue transglutaminase expression promotes cell attachment, invasion and survival in breast cancer cells. Oncogene 26(17):2459–2470
Mann AP, Verma A, Sethi G, Manavathi B, Wang HM, Fok JY, Kunnumakkara AB, Kumar R, Aggarwal BB, Mehta K (2006) Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-kappa B in cancer cells: delineation of a novel pathway. Cancer Res 66(17):8788–8795
McHale MK, Setton LA, Chilkoti A (2005) Synthesis and in vitro evaluation of enzymatically cross-linked elastin-like polypeptide gels for cartilaginous tissue repair. Tissue Eng 11(11–12):1768–1779
Mehta K (1994) High levels of transglutaminase expression in doxorubicin-resistant human breast carcinoma cells. Int J Cancer 58(3):400–406
Mian S, el Alaoui S, Lawry J, Gentile V, Davies PJ, Griffin M (1995) The importance of the GTP-binding protein tissue transglutaminase in the regulation of cell cycle progression. Febs Lett 370(1–2):27–31
Mirza A, Liu SL, Frizell E, Zhu JL, Maddukuri S, Martinez J, Davies P, Schwarting R, Norton P, Zern MA (1997) A role for tissue transglutaminase in hepatic injury and fibrogenesis, and its regulation by NF-kappa B. Am J Physiol-Gastroint Liver Physiol 35(2):G281–G288
Mishra S, Murphy LJ (2004) Tissue transglutaminase has intrinsic kinase activity––identification of transglutaminase 2 as an insulin-like growth factor-binding protein-3 kinase. J Biol Chem 279(23):23863–23868
Nicholas B, Smethurst P, Verderio E, Jones R, Griffin M (2003) Cross-linking of cellular proteins by tissue transglutaminase during necrotic cell death: a mechanism for maintaining tissue integrity. Biochem J 371:413–422
O’Halloran DM, Russell JC, Griffin M, Pandit AS (2006) Characterization of a microbial transglutaminase cross-linked type II collagen scaffold. Tissue Eng 12(6):1467–1474
O’Halloran D, Grad S, Stoddart M, Dockery P, Alini M, Pandit AS (2008) An injectable cross-linked scaffold for nucleus pulposus regeneration. Biomaterials 29(4):438–447
Oliverio S, Amendola A, DiSano F, Farrace MG, Fesus L, Nemes Z, Piredda L, Spinedi A, Piacentini M (1997) Tissue transglutaminase-dependent posttranslational modification of the retinoblastoma gene product in promonocytic cells undergoing apoptosis. Mol Cell Biol 17(10):6040–6048
Orban JM, Wilson LB, Kofroth JA, El-Kurdi MS, Maul TM, Vorp DA (2004) Crosslinking of collagen gels by transglutaminase. J Biomed Mater A 68A(4):756–762
Piacentini M, Piredda L, Starace D, AnnicchiaricoPetruzzelli M, Mattei M, Oliverio S, Farrace MG, Melino G (1996) Differential growth of N- and S-type human neuroblastoma cells xenografted into SCID mice––correlation with apoptosis. J Pathol 180(4):415–422
Pinkas DM, Strop P, Brunger AT, Khosla C (2007) Transglutaminase 2 undergoes a large conformational change upon activation. Plos Biology 5(12):2788–2796
Raghunath M, Hopfner B, Aeschlimann D, Luthi U, Meuli M, Altermatt S, Gobet R, BrucknerTuderman L, Steinmann B (1996) Cross-linking of the dermo-epidermal junction of skin regenerating from keratinocyte autografts––anchoring fibrils are a target for tissue transglutaminase. J Clin Invest 98(5):1174–1184
Richards RJ, Masek LC, Brown RFR (1991) Biochemical and cellular mechanisms of pulmonary fibrosis. Toxicol Pathol 19(4):526–539
Shweke N, Boulos N, Jouanneau C, Vandermeersch S, Melino G, Dussaule JC, Chatziantoniou C, Ronco P, Boffa JJ (2008) Tissue transglutaminase contributes to interstitial renal fibrosis by favoring accumulation of fibrillar collagen through TGF-beta activation and cell infiltration. Am J Pathol 173(3):631–642
Skill NJ, Griffin M, El Nahas AM, Sanai T, Haylor JL, Fisher M, Jamie MF, Mould NN, Johnson TS (2001) Increases in renal epsilon-(gamma-glutamyl)-lysine crosslinks result from compartment-specific changes in tissue transglutaminase in early experimental diabetic nephropathy: pathologic implications. Lab Invest 81(5):705–716
Sperinde JJ, Griffith LG (1997) Synthesis and characterization of enzymatically-cross-linked poly(ethylene glycol) hydrogels. Macromolecules 30(18):5255–5264
Stenberg P, Roth EB, Sjoberg K (2008) Transglutaminase and the pathogenesis of coeliac disease. Eur J Intern Med 19(2):83–91
Summey BT, Graff RD, Lai TS, Greenberg CS, Lee GM (2002) Tissue transglutaminase localization and activity regulation in the extracellular matrix of articular cartilage. J Orthop Res 20(1):76–82
Takahashi H, Isobe T, Horibe S, Takagi J, Yokosaki Y, Sheppard D, Saito Y (2000) Tissue transglutaminase, coagulation factor XIII, and the pro- polypeptide of von Willebrand factor are all ligands for the integrins alpha(9)beta(1) and alpha(4)beta(1). J Biol Chem 275(31):23589–23595
Tanaka K, Yokosaki Y, Higashikawa F, Saito Y, Eboshida A, Ochi M (2007) The integrin alpha 5 beta 1 regulates chondrocyte hypertrophic differentiation induced by GTP-bound transglutaminase 2. Matrix Biol 26(6):409–418
Telci D, Griffin M (2006) Tissue transglutaminase (TG2)––a wound response enzyme. Front Biosci 11:867–882
Telci D, Wang Z, Li X, Verderio EAM, Humphries MJ, Baccarini M, Basaga H, Griffin M (2008) Fibronectin-tissue transglutaminase matrix rescues RGD-impaired cell adhesion through syndecan-4 and beta(1) integrin co-signaling. J Biol Chem 283(30):20937–20947
Tovar-Vidales T, Roque R, Clark AF, Wordinger RJ (2008) Tissue transglutaminase expression and activity in normal and glaucomatous human trabecular meshwork cells and tissues. Ophthalmol Vis Sci 49(2):622–628
Ueki S, Takagi J, Saito Y (1996) Dual functions of transglutaminase in novel cell adhesion. J Cell Sci 109(Pt 11):2727–2735
Upchurch HF, Conway E, Patterson MK Jr, Birckbichler PJ, Maxwell MD (1987) Cellular transglutaminase has affinity for extracellular matrix. In Vitro Cell Dev Biol 23(11):795–800
Upchurch HF, Conway E, Patterson MK, Maxwell MD (1991) Localization of cellular transglutaminase on the extracellular matrix after wounding––characteristics of the matrix bound enzyme. J Cell Physiol 149(3):375–382
Verderio E, Coombes A, Jones RA, Li XL, Heath D, Downes S, Griffin M (2001) Role of the cross-linking enzyme tissue transglutaminase in the biological recognition of synthetic biodegradable polymers. J Biomed Mater Res 54(2):294–304
Verderio E, Gross SR, Griffin M (1999) Cell-surface tissue transglutaminase regulates matrix storage of latent TGF-beta binding protein-1 (LTBP-1) and fibronectin accumulation. Mol Biol Cell 10:370
Verderio EA, Scarpellini A and Johnson TS (2008) Novel interactions of TG2 with heparan sulfate proteoglycans: reflection on physiological implications. Amino Acids (in press)
Verderio EAM, Johnson TS, Griffin M (2005) Transglutaminases in wound healing and inflammation. Prog Exp Tumor Res 38:89–114
Verderio EAM, Telci D, Okoye A, Melino G, Griffin M (2003) A novel RGD-independent cell adhesion pathway mediated by fibronectin-bound tissue transglutaminase rescues cells from anoikis. J Biol Chem 278(43):42604–42614
Weiss MS, Metzner HJ, Hilgenfeld R (1998) Two non-proline cis peptide bonds may be important for factor XIII function. Febs Lett 423(3):291–296
Welge-Lussen U, May CA, Lutjen-Drecoll E (2000) Induction of tissue transglutaminase in the trabecular meshwork by TGF-beta 1 and TGF-beta 2. Invest Ophthalmol Vis Sci 41(8):2229–2238
Wilhelmus M, Andringa G, Bol J, Van Dam AM, Hoozemans J, Jongenelen C, Breve J, Boekel A, Drukarch B (2007) Tissue transglutaminase is activated and redistributed to ER-derived granules in neuroblastoma cells treated with the PD-mimicking neurotoxin MPP. Park Rel Dis 13:S135–S135
Zemskov EA, Janiak A, Hang J, Waghray A, Belkin AM (2006) The role of tissue transglutaminase in cell-matrix interactions. Front Biosci 11:1057–1076
Zemskov EA, Mikhailenko I, Strickland DK, Belkin AM (2007) Cell-surface transglutaminase undergoes internalization and lysosomal degradation: an essential role for LRP1. J Cell Sci 120(18):3188–3199
Zhu Y, Tramper J (2008) Novel applications for microbial transglutaminase beyond food processing. Trends Biotechnol 26(10):559–565
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Collighan, R.J., Griffin, M. Transglutaminase 2 cross-linking of matrix proteins: biological significance and medical applications. Amino Acids 36, 659–670 (2009). https://doi.org/10.1007/s00726-008-0190-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-008-0190-y